FdaApplication
NDA 020505
Identifiers
- fda_app_no: NDA020505
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1996-12-24 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOPAMAX | TOPIRAMATE | 400MG | TABLET;ORAL |
| TOPAMAX | TOPIRAMATE | 300MG | TABLET;ORAL |
| TOPAMAX | TOPIRAMATE | 50MG | TABLET;ORAL |
| TOPAMAX | TOPIRAMATE | 25MG | TABLET;ORAL |
| TOPAMAX | TOPIRAMATE | 200MG | TABLET;ORAL |
| TOPAMAX | TOPIRAMATE | 100MG | TABLET;ORAL |
6 products